Team:PKU Beijing/Project/AND Gate 2 Design
From 2009.igem.org
(Difference between revisions)
Line 16: | Line 16: | ||
Another design of the second AND Gate is to make a hybrid promoter, which can be activated by salicylate, and repressed by CI434. This hybrid promoter regulates the expression of PhiR73 delta/T3pol (this time, no amber mutation). | Another design of the second AND Gate is to make a hybrid promoter, which can be activated by salicylate, and repressed by CI434. This hybrid promoter regulates the expression of PhiR73 delta/T3pol (this time, no amber mutation). | ||
+ | |||
Because what we take is the first strategy, the second design is just discussed briefly below: | Because what we take is the first strategy, the second design is just discussed briefly below: | ||
+ | |||
First, we should figure out the -35 region and the -10 region of the salicylate inducible promoter. Then, the region between -35 and -10 is replaced with a CI434 binding site. Another CI434 binding site is placed downstream of -10 region. In this way, the promoter is silenced when CI434 is bound. After CI434 is removed from the system, this hybrid promoter still needs salicylate to activate. | First, we should figure out the -35 region and the -10 region of the salicylate inducible promoter. Then, the region between -35 and -10 is replaced with a CI434 binding site. Another CI434 binding site is placed downstream of -10 region. In this way, the promoter is silenced when CI434 is bound. After CI434 is removed from the system, this hybrid promoter still needs salicylate to activate. |
Revision as of 15:48, 13 October 2009